Ekstrakraniel stereotaktisk strlebehandling Aarhus

1
A prospective trial on stereotactic radiotherapy
of limited stage non-small cell lung cancer M.
Hoyer, H. Roed, A. Traberg, L. Ohlhuis, J.
Pedersen,A. K. Bertelsen, H. Nellemann, C. Grau,
Sv. A. Engelholm and H. von der Maase
Danish Stereotactic Radiotherapy Group Danish
Lung Cancer Group Aarhus University Hospital
Copenhagen University Hospital
2
NSCLC Stage I
3
Phase-II study Stereotactic radiotherapy of
limited stage non-small cell lung cancer
4
BEFORE
6 MONTHS AFTER
5
Phase-II study Stereotactic radiotherapy of
limited stage non-small cell lung cancer
NSCLC Stage I
6
Phase-II study Stereotactic radiotherapy of
limited stage non-small cell lung cancer
7
Phase-II study Stereotactic radiotherapyof
limited stage non-small cell lung cancer
NSCLC Stage I
8
Phase-II study Stereotactic radiotherapy of
limited stage non-small cell lung cancer
9
Phase-II study Stereotactic radiotherapy of
limited stage non-small cell lung cancer
10
Morbidity within 6 months
Grade gt 2 in 48 of the patients
11
Phase-II study Stereotactic radiotherapy of
limited stage non-small cell lung cancer
Conclusions

• Local control rate of 85 after 2 years
• Moderate toxicity
• Progression free survival rate of 54 after 2
  years
• Survival rate of 47 after 2 years

12
Faculty Paul Okunieff Robert Timmerman Laura
Dawson Reinhard Wurm Ingmar Lax Rolf
Lewensohn Ben Slotman Klaus Herfarth Jörn
Wulff Michael Molls Håkan Nyström Jens
Overgaard Morten Hoyer Jacob Lindegaard Cai Grau